We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Topotecan in Patients With Refractory Acute Leukemia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00100477
First Posted: December 31, 2004
Last Update Posted: September 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Immunex Corporation
SmithKline Beecham
Amgen
Information provided by (Responsible Party):
VA Office of Research and Development
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2001
  Primary Completion Date: January 2001 (Final data collection date for primary outcome measure)